Many high-ROIC companies with 12%+ EPS growth are having a slow year, are you buying? Meta Platforms $META is up 5% YTD Stock price is down 21% from its highs Return on Capital: 33% Earnings yield: 4% EPS has been growing > 12% Adobe Inc $ADBE is down -27% YTD Stock price is down 52% from its highs Return on Capital: 46% Earnings yield: 4% EPS has been growing > 12% Strong buybacks MSIC $MSCI is down -3% YTD Stock price is down 13% from its highs Return on Capital: 45% EPS has been growing > 12% Cannibal stock Mastercard $MA is up 5% YTD Stock price is down 8% from its highs Return on Capital: 68% Earnings yield: 3% EPS has been growing > 12% Strong buybacks Fair Isaac Corporation $FICO is down -13% YTD Stock price is down 27% from its highs Return on Capital: 70% EPS has been growing > 12% Cannibal stock lululemon athletica $LULU is down -56% YTD Stock price is down 68% from its highs Return on Capital: 40% Earnings yield: 9% EPS has been growing > 12% Booking Holdings $BKNG is down -0.56% YTD Stock price is down 15% from its highs Return on Capital: 71% Earnings yield: 3% EPS has been growing > 12% Cannibal stock Ameriprise Financial $AMP is down -13% YTD Stock price is down 20% from its highs Return on Capital: 67.07% Earnings yield: 8% EPS has been growing > 12% Cannibal stock Domino's Pizza $DPZ is down -2% YTD Stock price is down 27% from its highs Return on Capital: 86% Earnings yield: 4% EPS has been growing > 12% Cannibal stock Copart $CPRT is down 29% YTD Stock price is down 37% from its highs Return on Capital: 19% EPS has been growing > 12% Strong buybacks Novo Nordisk $NVO is down -46% YTD Stock price is down 71% from its highs Return on Capital: 53% Earnings yield: 8% EPS has been growing > 12%

Nov 7, 2025 · 11:19 PM UTC

13
21
202
And the CEO is confident about the future of the company.
$ADBE CEO: we believe our stock is undervalued so we are buying back a lot of our shares right now
2
Replying to @BourbonCap
CPRT, ADBE and META are my 3 buys from here
1
1
The ability of Copart to generate quick cash in less than 12 months is incredibly high.
1
5
Replying to @BourbonCap
$NVO $ADBE $META offer a lot of value
$NVO stock is currently trading near its 2021 lows, despite revenue having more than doubled since then. While Eli Lilly has delivered a solid 13.7% stock gain over the past year, Novo has declined by 56.3%, even though both companies have posted comparable growth during that period. This disconnect between stock performance and fundamental strength suggests significant potential upside for Novo as the market grows tired of semiconductor companies.
1
Replying to @BourbonCap
META EPS ain’t growing 12% next year. Obvi a great company and probably a buy, but not until everyone figures out there will be no/negative EPS growth in 2026
The forecast remains the same for now, but it will probably be affected.
Replying to @BourbonCap
Great list👍, but $CPRT doest no do buybacks (shares outstanding is increasing).
1
Replying to @BourbonCap
you did not listen valuation ie pe or p/fcf
Replying to @BourbonCap
High ROIC for now. ROIC headed much much lower.
Replying to @BourbonCap
$META and $NVO it’s big buy for me !
Replying to @BourbonCap
$FICO is no brainer choice 🤷🏻‍♂️
Replying to @BourbonCap
why the magic 12% ??? Stock price should follow EPS growth or expected EPS growth
1
From chemicals to gas to energy solutions, we invest with discipline and partner with purpose to generate long-term value.
22
37
529